Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

David C Dale, MD, Frank Caleb Firkin, MD, Audrey Anna Bolyard, RN, BS, Merideth L. Kelley, MSc, Emily Dick, BA, Sonja Hartmann, PhD, Karen Brown, PhD, Tarek M Ebrahim, MD, Kenneth J Gorelick, MD, Sudha Parasuraman, MD

Blood (2018) 132 (Supplement 1): 1102.

https://doi.org/10.1182/blood-2018-99-119840

Published: 2018

Journal Articles

Selective Splenic Artery Embolization for the Treatment of Thrombocytopenia and Hypersplenism in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Anna Paola Iori, Karen Brown, David J. Araten, Emilia Scalzulli, Giovanni Fernando Torelli, Maria Stefania De Propris, Corrado Girmenia, Filippo Maria Salvatori, Orly Zelig, Robin Foa, MD, Lucio Luzzatto

Blood (2012) 120 (21): 4408.

https://doi.org/10.1182/blood.V120.21.4408.4408

Published: 2012

Journal Articles

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

Chenthil Rathnasabapathy, MD, Kathleen West, Ph.D, Gerald Fetterly, Ph.D, Minocher Battiwalla, MD, Shannon L Smiley, MD, Theresa Hahn, PhD, Karen Brown, NP, Karen Arnold, NP, Margaret Syta, NP, Pamela Paplham, NP, Joann Liu, NP, Philip L. McCarthy, MD

Blood (2009) 114 (22): 2276.

https://doi.org/10.1182/blood.V114.22.2276.2276

Published: 2009

Journal Articles

High Frequency and Early Onset of Bone Mineral Density Loss Following Allogeneic Stem Cell Transplantation.

Lauren M. Dunford, BA, David M. Roy, Theresa Hahn, PhD, Karen Brown, MS, FNP-C, ONP, Pamela Paplham, MS, FNP, ONP, Dominick M. Lamonica, MD, Minoo Battiwalla, MD, MS, Swaminathan Padmanabhan, MD, Philip L. McCarthy, Jr., MD

Blood (2005) 106 (11): 2011.

https://doi.org/10.1182/blood.V106.11.2011.2011

Published: 2005

Journal Articles

Factor V Cambridge: A New Mutation (Arg 306 →Thr) Associated With Resistance to Activated Protein C

David Williamson, Karen Brown, Roger Luddington, Caroline Baglin, Trevor Baglin

Blood (1998) 91 (4): 1140–1144.

https://doi.org/10.1182/blood.V91.4.1140

Published: 1998

NARROW

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

Selective Splenic Artery Embolization for the Treatment of Thrombocytopenia and Hypersplenism in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

High Frequency and Early Onset of Bone Mineral Density Loss Following Allogeneic Stem Cell Transplantation.

Factor V Cambridge: A New Mutation (Arg 306 →Thr) Associated With Resistance to Activated Protein C

Email alerts

ASH Publications

American Society of Hematology

Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome

Selective Splenic Artery Embolization for the Treatment of Thrombocytopenia and Hypersplenism in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

High Frequency and Early Onset of Bone Mineral Density Loss Following Allogeneic Stem Cell Transplantation.

Factor V Cambridge: A New Mutation (Arg 306 →Thr) Associated With Resistance to Activated Protein C

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only